← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aimmax Therapeutics, Inc.
Durham, NC
$4,890,109
Total funding
4
Grants
Funding over time
peak $1.6M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,890,109 · 4
By mechanism
R44$3,663,308 · 2
R43$1,226,801 · 2
Investigators at Aimmax Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$1,049,943
R44 · FY2025 · AI
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$999,991
R44 · FY2024 · AI
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$999,962
R44 · FY2023 · AI
Development of a Novel Injectable Antibiotic to Treat Serious Multidrug-resistant Gram-positive Infections$306,954
R43 · FY2023 · AI
Development of a Novel Injectable Antibiotic to Treat Serious Multidrug-resistant Gram-positive Infections$306,953
R43 · FY2024 · AI
Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea$306,915
R44 · FY2022 · AI
A Single Dose Therapy to Treat Drug Resistant Gonorrhea$306,497
R44 · FY2024 · AI
Optimization and Characterization of Novel Antifungal Peptides$306,486
R43 · FY2022 · AI
Optimization and Characterization of Novel Antifungal Peptides$306,408
R43 · FY2023 · AI